Clean Science Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹299 Cr +22% YoYSee revenue, profit and what management said. You are viewing Q4 FY25.
CS

Clean Science

Q4 FY25Chemicals & Petrochemicals

Clean Science Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 earnings call: what management said on revenue, margins and capex.

Revenue
₹264Cr
+15.8% YoY
+9.5% QoQ
Net profit
₹74Cr
+5.7% YoY
+12.1% QoQ
Margin
40%
−2 pp YoY
−1 pp QoQ
Price₹822
Market cap₹8.8K Cr
P/E37.7

The short version

Revenue potential is estimated between Rs. 2,500 crores to Rs. 3,000 crores, likely over the next three years. Revenue potential is expected to be Rs. 2,500 to Rs. 3,000 crores within the next three years.

From Clean Science's Q4 FY25 earnings-call transcript · updated 26 Aug 2026.

Revenue & Sales Performance

  • Revenue potential is estimated between Rs. 2,500 crores to Rs. 3,000 crores, likely over the next three years.
  • Existing products are expected to grow at an industry rate of 5-6% annually.
  • New product launches, including performance chemicals and HALS, will drive significant growth and absorb overheads.
  • HALS sales target: from Rs. 80 crores in FY '25 to Rs. 210 crores in FY '26 and ramping up fully by FY '27-’28 with total capacity over 10,000 tons.
  • Performance chemicals (two new products) to commercialize in FY '26; revenue contribution expected mostly from FY '27 onward.
  • MEHQ volumes anticipated to grow 4%-5% year-on-year.

2 more points from Clean Science's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Clean Science said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • FY ’25 CAPEX: Rs. 215 crores invested in subsidiary Clean Fino-Chem.
  • FY ’26 CAPEX: Rs. 300 crores planned, primarily for two new performance chemical projects.
  • One product commercialization expected by August FY ’26.
  • Second product commercialization expected by February FY ’26.
  • Further CAPEX plans for FY ’27 will be announced around six months after these products come online.

2 more points from Clean Science's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Clean Science said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Clean Science said on order book & pipeline — free account, 30 seconds.

Clean Science — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Clean Science Q4 FY25 results — key figures

Clean Science Q4 FY25 reported results vs Q4 FY24, ₹ crore
₹ CrQ4 FY25Q4 FY24YoYQ3 FY25QoQ
Revenue264228+15.8%241+9.5%
Operating profit (EBITDA)10595+10.5%98+7.1%
Operating margin40%42%-2 pp41%-1 pp
Profit before tax10095+5.3%85+17.6%
Net profit (PAT)7470+5.7%66+12.1%
EPS (₹)6.976.61+5.4%6.18+12.8%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹299 Cr, net profit ₹56 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Atul (Q4 FY25)

    Consolidated revenue from operations for 2024-25: ₹5,583 cr, 18% increase YoY from ₹4,726 cr in 2023-24 (Page 36). Key concall takeaways from Atul Ltd's Q4…

  • Vidhi Specialty (Q4 FY25)

    109.5 Crs, up 40.2% YoY (from Rs. Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q4 FY25 earnings call — and how it ranks against sector…

  • Chemcon Speciality Chemicals (Q4 FY25)

    54.9 Crs, down 8% YoY from Rs. Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.

  • Valiant Organics (Q4 FY25)

    Q4-FY25 revenue from operations (consolidated) was INR 2,038 million, a 15.3% year-on-year (YoY) increase from INR 1,768 million in Q4-FY24 (Page 12 and 10)…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Clean Science and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Clean Science Q4 FY25 results?

Revenue potential is estimated between Rs. 2,500 crores to Rs. 3,000 crores, likely over the next three years. Revenue potential is expected to be Rs. 2,500 to Rs. 3,000 crores within the next three years.

What is Clean Science share price analysis?

Clean Science currently shows a neutral. The stock trades at a P/E of 37.7 with a market cap of ₹8,774 Cr. Investors should review the full earnings analysis for detailed insights.

Is Clean Science planning capital expenditure?

FY ’25 CAPEX: Rs. 215 crores invested in subsidiary Clean Fino-Chem.

Keep Clean Science on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.